Hansen K - Search Results

1

The 6-month persistence on SSRIs and associated economic burden.

Ereshefsky L, Saragoussi D, Despiégel N, Hansen K, François C, Maman K. Ereshefsky L, et al. Among authors: hansen k. J Med Econ. 2010;13(3):527-36. doi: 10.3111/13696998.2010.511050. J Med Econ. 2010. PMID: 20701432 Free article.

2

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N. Wade AG, et al. Among authors: hansen k. Pharmacoeconomics. 2008;26(11):969-81. doi: 10.2165/00019053-200826110-00008. Pharmacoeconomics. 2008. PMID: 18850765 Clinical Trial.

3

A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway.

François C, Toumi M, Aakhus AM, Hansen K. François C, et al. Among authors: hansen k. Eur J Health Econ. 2003;4(1):12-9. doi: 10.1007/s10198-002-0139-0. Eur J Health Econ. 2003. PMID: 15609164

4

Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder.

Xie F, Despiegel N, Danchenko N, Hansen K. Xie F, et al. Among authors: hansen k. Int J Psychiatry Clin Pract. 2009;13(1):59-69. doi: 10.1080/13651500802450506. Int J Psychiatry Clin Pract. 2009. PMID: 24946123

5

A pharmacoeconomic evaluation of zuclopenthixol compared with haloperidol and risperidone in the treatment of schizophrenia.

Hansen K, François C, Toumi M, Lançon C. Hansen K, et al. Eur J Health Econ. 2002;3(3):173-9. doi: 10.1007/s10198-002-0128-3. Eur J Health Econ. 2002. PMID: 15609142

6

Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.

Sawyer L, Azorin JM, Chang S, Rinciog C, Guiraud-Diawara A, Marre C, Hansen K. Sawyer L, et al. Among authors: hansen k. J Med Econ. 2014 Jul;17(7):508-19. doi: 10.3111/13696998.2014.914030. Epub 2014 Apr 30. J Med Econ. 2014. PMID: 24720805 Free article.

7

Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States.

Citrome L, Kamat SA, Sapin C, Baker RA, Eramo A, Ortendahl J, Gutierrez B, Hansen K, Bentley TG. Citrome L, et al. Among authors: hansen k. J Med Econ. 2014 Aug;17(8):567-76. doi: 10.3111/13696998.2014.917089. Epub 2014 May 12. J Med Econ. 2014. PMID: 24758296 Free article.

8

A prospective study of health care resource utilisation and selected costs of schizophrenia in France.

Sarlon E, Heider D, Millier A, Azorin JM, König HH, Hansen K, Angermeyer MC, Aballéa S, Toumi M. Sarlon E, et al. Among authors: hansen k. BMC Health Serv Res. 2012 Aug 21;12:269-76. doi: 10.1186/1472-6963-12-269. BMC Health Serv Res. 2012. PMID: 22909284 Free PMC article.

9

Parents of children with atopic diseases - experiences with care and the interaction with healthcare professionals over time.

Færk G, Søndergaard E, Skov L, Thyssen JP, Hansen KS, Reventlow S. Færk G, et al. Among authors: hansen ks. Scand J Prim Health Care. 2024 Jun 3:1-10. doi: 10.1080/02813432.2024.2357794. Online ahead of print. Scand J Prim Health Care. 2024. PMID: 38829768

10

Referral Pathways for Children with Atopic Diseases in Denmark.

Færk G, Ahlström MG, Lura VH, Reventlow S, Johansen JD, Thyssen JP, Hansen KS, Skov L. Færk G, et al. Among authors: hansen ks. Acta Derm Venereol. 2024 Jun 3;104:adv34961. doi: 10.2340/actadv.v104.34961. Acta Derm Venereol. 2024. PMID: 38828609 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,489 results

Search Page